Back

Evaluation of an artificial intelligence-enhanced closed-loop digital system for risk factor control in coronary heart disease: a randomized clinical trial

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Digital health interventions in cardiology: randomised trials and real-world implementation m-Health & Mobile Apps ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Zhengqing Ba

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

6 More presentations in this session

Presentation thumbnail
A community-driven digital health intervention for cardiovascular risk factor control: a cluster randomized controlled Trial
Doctor Y. Gu (Beijing, CN)
Abstract
Presentation thumbnail
Health literacy and response to a mobile app–based exercise programme in heart failure: Insights from the EXERCISE-HF trial
Doctor K. Daigo (Tokyo, JP)
Abstract
Presentation thumbnail
Initial efficacy and feasibility of a novel patient support program for patients with cardiac implantable electronic devices and remote monitoring - the PARTICIPATE randomised controlled trial
Doctor B. Sheahen (Westmead, AU)
Abstract
Presentation thumbnail
Digital health divide by age: smartphone and wearable adoption patterns and perceived utility to improve health
Doctor C. Schach (Regensburg, DE)
Abstract
Presentation thumbnail
Evaluation of a human-in-the-loop pre-procedural clinical conversational AI calling system for cardiac catheterisation
Doctor G. Dangas (New York, US)
Abstract

Access the full session

Session thumbnail
Digital health interventions in cardiology: randomised trials and real-world implementation

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of individualized intelligent behavioral interventions on health behaviors for patients with coronary heart disease: an open-label, multicenter, parallel-group, randomized controlled trial
1 September 2025
thumbnail
Congress Session
Artificial intelligence in preventive cardiology: implications for lipid-lowering therapy management
30 August 2026
thumbnail
Congress Presentation
The use of ophthalmic fundus imaging to predict cardiovascular risk factors: a systematic review
5 April 2025
thumbnail
Congress Presentation
Addressing the gap: LDL cholesterol control in high-risk patients with acute chest pain in a reference cardiology hospital in brazil
15 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources